Insider Purchases of Penny Stocks -
98 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2019-01-23 | ABMC | American Bio Medica Corp | Davis Chaim | Dir | P - Purchase | $0.10 | +500,000 | 2,582,451 | +24% | +$50,000 | |||||
2019-02-01 | ACCA | Acacia Diversified Holdings, Inc. | Gholson Neil B. | Dir | P - Purchase | $0.12 | +250,000 | 1,200,000 | +26% | +$30,000 | ||||||
2018-12-07 | ACTG | Acacia Research Corp | Tobia Alfred Victor Jr. | Dir | P - Purchase | $3.00 | +9,654 | 1,200,000 | +1% | +$28,983 | ||||||
2019-01-15 | AGGX | Angiogenex, Inc. | Aronstein Michael | CHAIRMAN, 10% | P - Purchase | $0.20 | +1,000,000 | 5,500,000 | +22% | +$200,000 | ||||||
| D | 2018-12-26 | AIRI | Air Industries Group | Melluzzo Luciano M | Pres | P - Purchase | $0.79 | +30,000 | 70,000 | +75% | +$23,698 | |||||
| DM | 2019-02-15 | ALJJ | Alj Regional Holdings Inc | Ravich Jess M | Exec COB, 10% | P - Purchase | $1.82 | +152,768 | 14,306,178 | +1% | +$278,408 | |||||
| M | 2019-02-13 | AMAR | Amarillo Biosciences Inc | Chen Stephen T | Pres,COB,CEO,CFO, 10% | P - Purchase | $0.25 | +151,000 | 6,767,360 | +2% | +$37,900 | |||||
| M | 2019-01-23 | APDN | Applied Dna Sciences Inc | Montgomery William W | 10% | P - Purchase | $0.47 | +140,000 | 5,230,900 | +3% | +$65,244 | |||||
2019-02-01 | BAMM | Body & Mind Inc. | Australis Capital Inc | 10% | P - Purchase | $0.44 | +1,768,545 | 22,079,788 | +9% | +$778,160 | ||||||
2019-02-11 | BFGC | Bullfrog Gold Corp. | Thygesen Kjeld | Dir | P - Purchase | $0.07 | +1,500,000 | 2,500,000 | +150% | +$100,000 | ||||||
2019-01-25 | BLPH | Bellerophon Therapeutics, Inc. | Peacock Jonathan M | Dir | P - Purchase | $0.70 | +714,286 | 1,855,920 | +63% | +$500,000 | ||||||
2019-01-25 | BLPH | Bellerophon Therapeutics, Inc. | Amin Naseem | Dir | P - Purchase | $0.70 | +571,429 | 1,818,867 | +46% | +$400,000 | ||||||
2019-01-25 | BLPH | Bellerophon Therapeutics, Inc. | Wang Theodore T | Dir, 10% | P - Purchase | $0.70 | +450,000 | 463,699 | >999% | +$315,000 | ||||||
| M | 2019-01-11 | BSGM | Biosig Technologies, Inc. | Londoner Kenneth L | CEO, 10% | P - Purchase | $4.35 | +18,700 | 643,843 | +3% | +$81,408 | |||||
2019-01-31 | CGIX | Cancer Genetics, Inc | Roberts John A | CEO | P - Purchase | $0.23 | +185,436 | 297,636 | +165% | +$42,650 | ||||||
2019-01-31 | CGIX | Cancer Genetics, Inc | Miles Michael Glenn | CFO | P - Purchase | $0.23 | +150,000 | 150,000 | New | +$34,500 | ||||||
2019-01-31 | CGIX | Cancer Genetics, Inc | Cannon Edmund | Dir | P - Purchase | $0.23 | +43,479 | 61,873 | +236% | +$10,000 | ||||||
2019-01-31 | CGIX | Cancer Genetics, Inc | Pappajohn John | Dir | P - Purchase | $0.23 | +1,000,000 | 4,781,204 | +26% | +$230,000 | ||||||
2019-01-15 | CTIB | Cti Industries Corp | Schwan John H | COB, 10% | P - Purchase | $3.32 | +180,723 | 1,003,439 | +22% | +$600,000 | ||||||
| M | 2019-01-22 | DEST | Destination Maternity Corp | Kingdon Capital Management, L.L.C. | See Remarks | P - Purchase | $3.08 | +39,559 | 174,816 | +29% | +$121,912 | |||||
2019-02-20 | DPW | Dpw Holdings, Inc. | Ault & Company, Inc. | See Remark | P - Purchase | $0.12 | +1,000,000 | 1,722,024 | +138% | +$120,000 | ||||||
2019-02-15 | DPW | Dpw Holdings, Inc. | Ault & Company, Inc. | See Remark | P - Purchase | $0.12 | +416,667 | 722,024 | +136% | +$50,000 | ||||||
| M | 2019-02-07 | DXLG | Destination Xl Group, Inc. | Cannell Capital LLC | 10% | P - Purchase | $2.47 | +4,261 | 5,212,539 | 0% | +$10,527 | |||||
2019-01-28 | EGLE | Eagle Bulk Shipping Inc. | Goldentree Asset Management LP | 10% | P - Purchase | $4.42 | +10,300 | 4,794,690 | 0% | +$45,526 | ||||||
| M | 2019-02-08 | EGLE | Eagle Bulk Shipping Inc. | Goldentree Asset Management LP | 10% | P - Purchase | $4.02 | +84,969 | 4,804,692 | +2% | +$341,819 | |||||
| M | 2019-02-12 | EGLE | Eagle Bulk Shipping Inc. | Goldentree Asset Management LP | 10% | P - Purchase | $4.55 | +174,363 | 4,826,959 | +4% | +$793,730 | |||||
| M | 2019-01-23 | EGLE | Eagle Bulk Shipping Inc. | Goldentree Asset Management LP | 10% | P - Purchase | $4.46 | +386,309 | 4,770,285 | +9% | +$1,723,752 | |||||
2019-02-11 | ENZN | Enzon Pharmaceuticals, Inc. | Couchman Jonathan | 10% | P - Purchase | $0.25 | +51,000 | 6,692,189 | +1% | +$12,750 | ||||||
| D | 2019-02-08 | EVFM | Evofem Biosciences, Inc. | Invesco Ltd. | 10% | P - Purchase | $2.64 | +425,531 | 9,590,688 | +5% | +$1,123,402 | |||||
2019-01-29 | FLUX | Flux Power Holdings, Inc. | Cleveland Capital Management, L.L.C. | 10% | P - Purchase | $1.10 | +497,100 | 5,656,200 | +10% | +$546,810 | ||||||
2019-01-30 | FTLF | Fitlife Brands, Inc. | Dayton Judd | CEO, 10% | P - Purchase | $0.50 | +224,455 | 3,362,178 | +7% | +$112,228 | ||||||
| M | 2019-01-28 | GALT | Galectin Therapeutics Inc | Uihlein Richard E | Dir, 10% | P - Purchase | $4.87 | +51,500 | 2,606,789 | +2% | +$250,559 | |||||
| AM | 2019-01-28 | GALT | Galectin Therapeutics Inc | Uihlein Richard E | Dir, 10% | P - Purchase | $4.87 | +51,500 | 2,586,789 | +2% | +$250,559 | |||||
| M | 2019-02-15 | GASS | Stealthgas Inc. | Glendon Capital Management LP | 10% | P - Purchase | $3.37 | +60,500 | 5,180,385 | +1% | +$203,879 | |||||
| M | 2019-02-13 | GEC | Great Elm Capital Group, Inc. | Reed Peter A | CEO | P - Purchase | $3.35 | +3,997 | 742,737 | +1% | +$13,372 | |||||
2019-01-22 | GGN | Gamco Global Gold, Natural Resources & Income Trust | Melarkey Michael J | Dir | P - Purchase | $3.99 | +3,953 | 3,953 | New | +$15,770 | ||||||
2019-02-11 | GLGI | Greystone Logistics, Inc. | Kruger Warren F | CEO, Pres, 10% | P - Purchase | $0.59 | +96,200 | 8,688,426 | +1% | +$56,373 | ||||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Chang Carmen | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Behbahani Ali | Dir, 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Baskett Forest | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Barris Peter J | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | New Enterprise Associates 16, L.P. | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Sonsini Peter W. | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Sandell Scott D | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Mott David M | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| D | 2019-02-14 | GNCA | Genocea Biosciences, Inc. | Makower Joshua | 10% | P - Purchase | $0.47 | +9,948,269 | 34,948,269 | +40% | +$4,688,619 | |||||
| M | 2019-01-28 | HIO | Western Asset High Income Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $4.70 | +23,985 | 13,901,695 | 0% | +$112,714 | |||||
2019-01-23 | HIO | Western Asset High Income Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $4.62 | +23,900 | 13,641,685 | 0% | +$110,418 | ||||||
| M | 2019-01-24 | HIO | Western Asset High Income Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $4.63 | +236,025 | 13,877,710 | +2% | +$1,092,796 | |||||
| DM | 2018-11-29 | IMH | Impac Mortgage Holdings Inc | Pickup Todd M | 10% | P - Purchase | $3.83 | +30,000 | 2,473,796 | +1% | +$114,787 | |||||
2019-02-12 | IPI | Intrepid Potash, Inc. | Clearway Capital Management Ltd. | 10% | P - Purchase | $3.22 | +200,000 | 17,069,822 | +1% | +$643,100 | ||||||
2019-02-12 | ISSC | Innovative Solutions & Support Inc | Askarpour Shahram | Pres | P - Purchase | $2.59 | +4,000 | 8,500 | +89% | +$10,370 | ||||||
| E | 2019-02-07 | KALO | Kallo Inc. | Kassett Rajni | 10% | P - Purchase | $0.04 | +3,731,005 | 23,698,279 | +19% | +$149,240 | |||||
| M | 2019-02-15 | LGCY | Legacy Reserves Inc. | Baines Creek Capital, LLC | 10% | P - Purchase | $1.36 | +150,000 | 25,464,537 | +1% | +$203,750 | |||||
| M | 2019-02-01 | LGCY | Legacy Reserves Inc. | Baines Creek Capital, LLC | 10% | P - Purchase | $1.50 | +175,000 | 25,314,537 | +1% | +$262,000 | |||||
| D | 2019-02-05 | LPTX | Leap Therapeutics, Inc. | Onsi Douglas E | CFO, GC, Treasurer, Secretary, 10% | P - Purchase | $1.75 | +571,428 | 4,458,693 | +15% | +$999,999 | |||||
| D | 2019-02-05 | LPTX | Leap Therapeutics, Inc. | Lawlor Augustine | COO, 10% | P - Purchase | $1.75 | +571,428 | 7,077,099 | +9% | +$999,999 | |||||
| D | 2019-02-05 | LPTX | Leap Therapeutics, Inc. | Mirabelli Christopher | CEO, Pres, COB, 10% | P - Purchase | $1.75 | +571,428 | 7,077,099 | +9% | +$999,999 | |||||
| D | 2019-02-05 | LPTX | Leap Therapeutics, Inc. | Healthcare Ventures Ix, L.P. | 10% | P - Purchase | $1.75 | +571,428 | 4,144,804 | +16% | +$999,999 | |||||
2019-02-15 | LTRX | Lantronix Inc | Yoder Kevin | VP of Worldwide Sales | P - Purchase | $2.85 | +7,000 | 66,668 | +12% | +$19,950 | ||||||
| D | 2019-02-06 | MLSS | Milestone Scientific Inc. | Osser Leonard | CEO, 10% | P - Purchase | $0.35 | +285,000 | 3,624,056 | +9% | +$99,750 | |||||
| M | 2019-02-06 | MSLP | Musclepharm Corp | Wynnefield Partners Small Cap Value LP I | 10% | P - Purchase | $0.40 | +100,000 | 1,871,305 | +6% | +$40,000 | |||||
| M | 2019-02-01 | NHLD | National Holdings Corp | Asher Daniel | 10% | P - Purchase | $3.25 | +878,932 | 5,987,954 | +17% | +$2,856,509 | |||||
2019-01-31 | NVAX | Novavax Inc | Glenn Gregory M | Pres, R, D | P - Purchase | $0.88 | +13,168 | 73,386 | +22% | +$11,588 | ||||||
| M | 2019-01-28 | OCN | Ocwen Financial Corp | Cooperman Leon G | 10% | P - Purchase | $1.67 | +275,007 | 8,590,670 | +3% | +$459,936 | |||||
2019-02-08 | OCX | Oncocyte Corp | Broadwood Partners, L.P. | 10% | P - Purchase | $3.75 | +533,333 | 16,199,679 | +3% | +$1,999,999 | ||||||
2019-02-07 | OTLK | Outlook Therapeutics, Inc. | Kenyon Lawrence A | CEO, Pres, CFO, Treas, Secy | P - Purchase | $0.90 | +25,000 | 82,213 | +44% | +$22,380 | ||||||
| M | 2019-01-30 | OTLK | Outlook Therapeutics, Inc. | Hilzinger Kurt J | Dir | P - Purchase | $0.75 | +19,390 | 178,964 | +12% | +$14,560 | |||||
| M | 2019-01-25 | OTLK | Outlook Therapeutics, Inc. | Hilzinger Kurt J | Dir | P - Purchase | $0.71 | +32,112 | 159,574 | +25% | +$22,691 | |||||
| D | 2019-01-31 | PENC | Pen Inc. | Berman Tom J. | Pres | P - Purchase | $0.40 | +47,120 | 47,120 | New | +$18,848 | |||||
| M | 2019-01-18 | QMCO | Quantum Corp /de/ | B. Riley Financial, Inc. | 10% | P - Purchase | $1.80 | +130,393 | 3,627,662 | +4% | +$234,778 | |||||
2019-02-14 | RASFN | Rait Financial Trust | Amster Howard | 10% | P - Purchase | $3.00 | +30,000 | 1,134,514 | +3% | +$90,000 | ||||||
| A | 2018-12-17 | REPR | Repro Med Systems Inc | Manko Joseph M. Jr. | Dir, 10% | P - Purchase | $1.20 | +45,000 | 11,274,191 | 0% | +$54,000 | |||||
2019-01-30 | RNN | Rexahn Pharmaceuticals, Inc. | Nolan Lisa | Chief Business Officer | P - Purchase | $0.65 | +20,000 | 21,625 | >999% | +$12,960 | ||||||
2019-01-29 | RNN | Rexahn Pharmaceuticals, Inc. | Swirsky Douglas J | Pres, CEO | P - Purchase | $0.63 | +50,000 | 50,000 | New | +$31,720 | ||||||
| M | 2019-01-29 | RSLS | Reshape Lifesciences Inc. | Sabby Management, LLC | 10% | P - Purchase | $0.28 | +60,200 | 1,182,206 | +5% | +$16,830 | |||||
| M | 2019-02-13 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +20,521 | 18,256,452 | 0% | +$15,014 | |||||
| D | 2019-02-04 | SEAC | Seachange International Inc | Singer Karen | 10% | P - Purchase | $1.57 | +85,908 | 4,986,125 | +2% | +$134,876 | |||||
| DM | 2019-02-07 | SEAC | Seachange International Inc | Singer Karen | 10% | P - Purchase | $1.63 | +50,504 | 5,036,629 | +1% | +$82,388 | |||||
2019-01-25 | SELB | Selecta Biosciences Inc | Nashat Amir | Dir | P - Purchase | $1.50 | +1,166,666 | 2,676,234 | +77% | +$1,749,999 | ||||||
| M | 2019-01-07 | SODI | Solitron Devices Inc | Olesen Value Fund L.P. | 10% | P - Purchase | $1.94 | +53,000 | 1,124,280 | +5% | +$102,850 | |||||
| DM | 2019-02-15 | STON | Stonemor Partners LP | Axar Capital Management L.P. | 10% | P - Purchase | $3.46 | +54,421 | 7,504,795 | +1% | +$188,446 | |||||
| DM | 2019-02-07 | STON | Stonemor Partners LP | Axar Capital Management L.P. | 10% | P - Purchase | $3.15 | +23,655 | 7,408,625 | 0% | +$74,528 | |||||
| DM | 2019-02-12 | STON | Stonemor Partners LP | Axar Capital Management L.P. | 10% | P - Purchase | $3.38 | +41,749 | 7,450,374 | +1% | +$141,088 | |||||
| D | 2019-01-02 | TDNT | Trident Brands Inc | Holcombe Mark R | Chair Comp. Com.&Board of Dir, 10% | P - Purchase | $0.38 | +150,000 | 24,950,000 | +1% | +$57,000 | |||||
2019-02-01 | TRVN | Trevena Inc | Moulder Leon O Jr | Dir | P - Purchase | $1.02 | +100,000 | 150,000 | +200% | +$102,000 | ||||||
2019-02-01 | TRVN | Trevena Inc | Gowen Maxine | Pres, CEO | P - Purchase | $1.02 | +50,000 | 470,012 | +12% | +$51,000 | ||||||
2019-02-14 | TYME | Tyme Technologies, Inc. | Michels Douglas A | Dir | P - Purchase | $3.26 | +20,000 | 60,000 | +50% | +$65,200 | ||||||
2019-02-07 | UEC | Uranium Energy Corp | Adnani Amir | CEO, Pres | P - Purchase | $1.34 | +10,500 | 2,661,654 | 0% | +$14,070 | ||||||
2019-02-07 | UEC | Uranium Energy Corp | Melbye Scott | EVP | P - Purchase | $1.34 | +9,500 | 244,099 | +4% | +$12,687 | ||||||
2019-02-15 | VERU | Veru Inc. | Fisch Harry | Dir, 10% | P - Purchase | $1.36 | +13,681 | 8,034,721 | 0% | +$18,654 | ||||||
| D | 2019-01-29 | VTVT | Vtv Therapeutics Inc. | Perelman Ronald O | 10% | P - Purchase | $1.84 | +815,217 | 14,863,219 | +6% | +$1,499,999 | |||||
| D | 2019-02-14 | VTVT | Vtv Therapeutics Inc. | Perelman Ronald O | 10% | P - Purchase | $1.84 | +815,217 | 15,678,436 | +5% | +$1,499,999 | |||||
| M | 2019-01-15 | VYST | Vystar Corp | Stone Bryan Lawrence | Dir | P - Purchase | $0.02 | +1,439,381 | 4,746,048 | +44% | +$34,808 | |||||
| D | 2019-02-11 | WKHS | Workhorse Group Inc. | Samuels H. Benjamin | Dir | P - Purchase | $0.95 | +841,934 | 1,622,848 | +108% | +$800,006 | |||||
| D | 2019-02-11 | WKHS | Workhorse Group Inc. | Budde Gerald B. | Dir | P - Purchase | $0.95 | +26,310 | 119,692 | +28% | +$25,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |